TransMedics Group, Inc. (NASDAQ:TMDX) Receives Consensus Rating of "Moderate Buy" from Analysts
TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eight analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1-year price objective […]